Here’s a snapshot of early confirmed attendees for AI for Pharma & Healthcare 2025: Pfizer, AstraZeneca, Johnson & Johnson, GSK, Roche, Novartis, Sanofi, Bayer, Takeda, and more. Senior leaders across drug discovery, clinical trials, supply chain, and AI strategy will be in the room—offering a focused, high-level audience actively investing in AI solutions. This is your opportunity to connect with the pharma teams driving real-world adoption.
As pharma and healthcare companies accelerate AI adoption, our latest report, The Pharma AI Revolution, reveals where investment is headed and what decision-makers need most.
Download to uncover:
Join 150+ C-level, VP & Director-level leaders from Sanofi, Syneos Health, Johnson & Johnson, Pfizer, MSD, Roche, GSK and more as they share both wins and lessons learned from embedding AI across R&D, clinical trials, regulatory, and commercial operations.
The rapid advancement of AI technology offers unprecedented opportunities for the pharmaceutical industry, where drug discovery moves at unprecedented speeds, clinical trials are streamlined for efficiency, and regulatory approvals are faster than ever before. However, sceptical of the "AI hype" pharma leaders need a clear path to AI integration.
This September, Pharma IQ is bringing together key AI stakeholders from big pharma responsible for drug discovery, clinical trials and supply chain to meet with key technology consultancies and vendors who will share practical applications and case studies.
Amongst the sea of AI events, AI for Pharma & Healthcare is uniquely positioned, there will be 3 streams consisting of drug discovery, clinical trials and supply chain to ensure that sponsors can showcase their expertise to a targeted audience from our three streams. The sponsorship prospectus has more information on the audience, key audience drivers and sponsorship package opportunities.